9.30am - 10.00am Registration and morning coffee

10.00am - 10.15am

OFFICIAL OPENING

The growth opportunity for life sciences in Australia

Glenn Cross, Chief Executive Officer, AusBiotech

10.15am - 10.25am

WELCOME ADDRESS

China Academy of Sciences

 

10.25am - 10.45am

KEYNOTE: Life sciences in China 2018 – what has changed in the past 12 months?

Speaker to be confirmed

 

10.45am - 11.15am

Company Spotlight Presentations

- Dr Brad Walsh, Chief Executive Officer, Minomic International

- Dr Rosalind Wilson, Chief Executive Officer, Factor Therapeutics (ASX:FFT)

- Dr Ross Macdonald, Managing Director and Chief Executive Officer, Cynata Therapeutics Limited (ASX:CYP)

 

11.15am - 11.45am Morning tea and networking opportunity

11.45am - 12.15pm

PANEL: China Deals – hot sectors for investment & partnering

Moderator: Rob Scott, Director, China BlueSky Partners

  • Li Fern Woo, Partner Life Sciences, KPMG Shanghai
  • Cherrie Che, Head of Strategy, Pfizer
  • Tom Folinsbee, Director, Corporate Development, 3SBio Inc.
  • Jimmy Zhang, Director, CI Investment Group
12.15pm - 1.00pm

Company Spotlight Presentations

- John Martin, Chief Executive Officer, Regeneus (ASX:RGS)

- Stephen Lydeamore, Chief Financial Officer, Bionomics Limited (ASX:BNO)

- Malcolm McColl, Managing Director and Chief Executive Officer, Viralytics Limited (ASX:VLA)

- David Nelson, Chief Executive Officer, CARP Pharmaceuticals - tbc

Rob Proulx, Chief Executive Officer, Imagion Biosystems (ASX:IBX)

 

1.00pm - 2.00pm

Lunch and networking opportunity

2.00pm - 2.30pm

PANEL: The face of life science investment in the new China

Moderator: Glenn Cross, Chief Executive Officer, AusBiotech Panelists:

  • Darren Ji, Venture Partner, Lilly Asia Ventures
  • Ben Ni, Operating Partner, I-Bridge Capital Partners
  • Malcolm McColl, Managing Director and Chief Executive Officer, Viralytics Limited
  • Marietta Wu, COO, Zai Lab (TBC)
  • Wayne Li, Investing Manager, Morningside Ventures (TBC)
  • Irene Zhang, Senior Investment Director, SUNGIN (TBC)
2.30pm - 3.15pm

Company Spotlight Presentations

- Companies to be confirmed

3.15pm - 3.45pm

Afternoon Tea and networking opportunity

3.45pm - 4.15pm

PANEL: Incubation in China as a pathway to success

Moderator: Rob Scott, Director, China BlueSky Partners

  • Cindy Zhai, Founder / General Manager, Shanghai Zhangjiang Joyin Innovation & Manufacturing Center
  • Sebastien Gaudin, CEO & Co-founder, The CareVoice
  • Cecilia Jiang, Senior Project Manager of Fenglin Biomedical Center, BioFM (TBC)
  • Daniel Zhan, Landing Pad Shanghai (Austrade)
4.15pm - 4.30pm

CLOSE - DAY ONE

Li Fern Woo, Partner Life Sciences, KPMG Shanghai

 

5.05pm - 7.00pm

Networking Reception
Venue: KPMG Hong Kong

The Blind Pig

132 Nanyang Lu, Jin’an District (5 minutes walk from KPMG)

9.30am - 10.00am      Registration and morning coffee

10.00am - 10.45am

KEYNOTE: Clinical Trials in Australia

  • Sue MacLeman, Managing Director and Chief Executive Officer, MTPConnect (MedTech and Pharma Growth Centre-MTP-IIGC Ltd), Australia

PANEL: Australia’s – Phase 1 Trial Fast Track

Moderator: Sue MacLeman, Managing Director and Chief Executive Officer, MTPConnect

Panelists from Australian trial sites:

  • Tina Soulis, Chief Executive Officer, Neuroscience Trials Australia
  • Jane Kelly, CEO, CMAX Clinical Research
  • Megan Ford, Senior Director Research & Development, IQVIA
10.45am - 11.15am

Company Spotlight Presentations

- Tina Soulis, Chief Executive Officer, Neuroscience Trials Australia

- Jane Kelly, CEO, CMAX Clinical Research

- Megan Ford, Senior Director Research & Development, IQVIA

 

11.15am - 11.30am Morning Tea and networking opportunity

11.30am - 12.15pm

Company Spotlight Presentations

- Dr Ryan Parlett, Director Business Management Pharma Services, Patheon Biologics Australia

- Jayden Rogers, VP Global Partnering, Linear Clinical Research

- Dr Kurt Lackovic, Chief Executive Officer, Cancer Trials Australia

 

12.15pm - 12.30pm

KEYNOTE: Update on IP in China

  • David Bennett, Counsellor (Intellectual Property), Australian Embassy, Beijing
12:30pm - 1:00pm

PANEL: Trusted Advisors in China

Moderator: Glenn Cross, Chief Executive Officer, AusBiotech

  • Hans Verheul, National Life Sciences Sector Lead, KPMG
  • David Bennett, Counsellor (Intellectual Property), Australian Embassy, Beijing
  • KingWoodMalleson (TBC)
1:00pm - 2:00pm

Lunch and networking opportunity

OFFICIAL CLOSE